Previous close | 117.48 |
Open | 0.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 1,161 |
Market cap | 133.799M |
Beta (5Y monthly) | 1.07 |
PE ratio (TTM) | 0.44 |
EPS (TTM) | 2.66 |
Earnings date | 22 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
While Alexandria's (ARE) Q1 earnings are likely to have benefited from the healthy demand for its high-quality life science and lab office properties, high interest expenses raise concern.
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Alexandria Real Estate Equities (ARE), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.
Robust demand for Alexandria's (ARE) high-quality life science and lab office properties in key markets, healthy operating performance and expansion efforts bode well for long-term growth.